Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study by Byun, Wonwoo et al.
University of South Carolina
Scholar Commons
Faculty Publications Epidemiology and Biostatistics
2-2011
Cardiorespiratory fitness and risk of prostate
cancer: Findings from the Aerobics Center
Longitudinal Study
Wonwoo Byun
University of South Carolina - Columbia
Xuemei Sui
University of South Carolina - Columbia
James R. Hébert
University of South Carolina - Columbia, jhebert@sc.edu
Timothy S. Church
I-Min Lee
See next page for additional authors
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_epidemiology_biostatistics_facpub
Part of the Public Health Commons
This Article is brought to you by the Epidemiology and Biostatistics at Scholar Commons. It has been accepted for inclusion in Faculty Publications by
an authorized administrator of Scholar Commons. For more information, please contact dillarda@mailbox.sc.edu.
Publication Info
Cancer Epidemiology, Volume 35, Issue 1, 2011, pages 59-65.
Byun, W., Sui, X., Hébert, J.R., Church, T.S., Lee, I-M., Matthews, C.E., & Blair, S.N. (2011). Cardiorespiratory fitness and risk of
prostate cancer: Findings from the Aerobics Center Longitudinal Study. Cancer Epidemiology, 35(1), 59-65.
DOI: 10.1016/j.canep.2010.07.013
NOTICE: This is the author's version of a work that was accepted for publication in Cancer Epidemiology. Changes resulting from the
publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be
reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was
subsequently published in Cancer Epidemiology, [Volume #35, Issue #1, (2011)] DOI: 10.1016/j.canep.2010.07.013




Wonwoo Byun, Xuemei Sui, James R. Hébert, Timothy S. Church, I-Min Lee, Charles E. Matthews, and
Steven N. Blair
This article is available at Scholar Commons: https://scholarcommons.sc.edu/sph_epidemiology_biostatistics_facpub/179
Cardiorespiratory fitness and risk of prostate cancer: Findings
from the Aerobics Center Longitudinal Study
Wonwoo Byuna,*, Xuemei Suia, James R. Hébertb,c, Timothy S. Churchd, I-Min Leee,
Charles E. Matthewsf, and Steven N. Blaira,b,c
a Department of Exercise Science, Arnold School of Public Health, University of South Carolina.
Columbia, SC, USA
b Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of
South Carolina. Columbia, SC, USA
c Cancer Prevention and Control Program, University of South Carolina. Columbia, SC, USA
d Preventive Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA,
USA
e Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School,
Boston, MA, USA
f Division of Cancer Epidemiology and Genetics, Nutritional Epidemiology Branch, National
Cancer Institute, Rockville, MD, USA
Abstract
Objective—To examine the association between cardiorespiratory fitness (CRF) and risk of
incident prostate cancer (PrCA).
Methods—Participants were 19,042 male subjects in the Aerobics Center Longitudinal Study
(ACLS), ages 20 to 82 years, who received a baseline medical examination including a maximal
treadmill exercise test between 1976 and 2003. CRF levels were defined as low (lowest 20%),
moderate (middle 40%), and high (upper 40%) according to age-specific distribution of treadmill
duration from the overall ACLS population. PrCA was assessed from responses to mail-back
health surveys during 1982 to 2004. Cox proportional hazards regression models, adjusted for
potential confounders, were used to compute hazard ratios (HRs), 95% confidence intervals (95%
CIs), and incidence rates (per 10,000 person-years of follow-up).
Results—A total of 634 men reported a diagnosis of incident PrCA during an average of 9.3 ±
7.1 years of follow-up. Adjusted HRs (95% CIs) in men with moderate and high CRF relative to
low CRF were, 1.68 (1.13–2.48) and 1.74 (1.15–2.62), respectively. The positive association
between CRF and PrCA was observed only in the strata of men who were not obese, had ≥ 1
follow-up examination, or who were diagnosed ≤ 1995.
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Conclusions—Rather than revealing a causal relationship, the unexpected positive association
observed between CRF and incident PrCA is most likely due to a screening/detection bias in more
fit men who also are more health-conscious. Results have important implications for
understanding the health-related factors that predispose men to receive PrCA screening that may
lead to over-detection of indolent disease.
Keywords
Cardiorespiratory fitness; Prostate cancer; Cohort studies; Attitude to health; Screening/detection
bias
1. Introduction
Prostate cancer (PrCA) is the most common cancer among men in the United States. Despite
relatively high incidence, PrCA has among the lowest virulence of any cancer [1].
According to the American Cancer Society, over 192,000 new cases of invasive PrCA were
diagnosed in 2009, accounting for 25% of all incident cancers in men. Approximately
27,400 men died of PrCA in 2009, accounting for 9% of all male cancer deaths [2]. Though
the etiology of PrCA is poorly understood, there are several potential genetic and
environmental/lifestyle risk factors associated with the disease, such as familial aggregation,
race/ethnicity, genetic variants in candidate genes (e.g., single nucleotide polymorphisms),
obesity, tobacco use, diet, and physical inactivity [3–6].
Physical activity may prevent the occurrence of PrCA through several hypothesized
mechanisms, including reduced concentration of circulating testosterone [7,8], modifications
in androgen receptor [8], obesity-related effects [9,10], reduced inflammation [11,12], and
enhanced immune function [13]. Results showing that higher endogenous testosterone levels
are associated with increased PrCA risk [14] and that elevated testosterone levels are seen
among men with PrCA [15] are consistent with the fact that the vast majority of PrCAs are
hormone dependent [7]. Therefore, the observation of acute decreases in testosterone levels
after exercise sessions [16], and decreased testosterone among male athletes compared to
nonathletes [17] are intriguing. Several prospective studies have suggested that physical
activity may reduce the risk of PrCA morbidity and mortality [18–20]. However, null or
positive associations between physical activity and risk of PrCA also have been reported
[21–26]. This inconsistency may be due to misclassification of exposure or recall bias in
physical activity using methods typically employed in large epidemiological studies or
problems with outcome ascertainment.
After an extensive literature review by an expert committee charged with reviewing the
scientific basis for the 2008 federal physical activity guidelines, there was a lack of evidence
to confirm a protective role of physical activity in PrCA prevention [27]. It has been
suggested that cardiorespiratory fitness (CRF), an objective marker for physical activity
habits, is a stronger predictor of overall mortality than self-reported physical activity [28–
30]. We are aware of only one study on the association of CRF with PrCA, an earlier report
from the Aerobic Center Longitudinal Study (ACLS) in which we reported a significant
reduction in PrCA risk in men with moderate to high CRF [31]. However, there were only
94 incident cases available for analysis at that time, and those data were collected prior to
substantial increases in PrCA screening that occurred in the mid-1990s. Thus, the purpose of
this study was to extend our earlier work by including a larger number of participants,
longer period of follow-up, more incident cases, and better control of potential confounders
of the CRF-PrCA association.
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2. Materials and methods
2.1. Study population
Between 1976 and 2003, 20,356 men aged 20–82 years received a medical examination, had
at least one mail-back survey at the Cooper Clinic in Dallas, TX, and were enrolled in the
ACLS, a prospective epidemiological investigation. The study protocol was approved
annually by the Institutional Review Board of the Cooper Institute, and all participants gave
informed consent to participate in the clinical examination and follow-up study.
Participants were not included in the present analyses if, at baseline, they did not achieve at
least 85% of age-predicted maximal heart rate (220-age) during the treadmill test (n=280),
they reported history of myocardial infarction (n=70), stroke (n=19), or cancer (n=188), they
were underweight (BMI<18.5 kg/m2) (n=665), or they had any exposure variables missing
(n=92). These criteria resulted in 19,042 men, ranging in age from 20–82 years, who were
followed up from the date of their baseline examination until their date of PrCA, or the date
of their last survey when they reported being free of PrCA. Among these men, 9,092
(47.8%) men also retuned to the Cooper Clinic after their baseline examination to receive
one or more follow-up clinical examination. These follow-up examinations were conducted
using the same protocols as the baseline examination. A majority of them were white
(>95%), approximately 80% were college graduates, and most worked in (or were retired
from) professional or executive positions. The participants had no prior history of cancer,
heart attack or stroke. Study participants came to the clinic for periodic preventive health
examinations and to receive counseling regarding diet, exercise, and other lifestyle factors
associated with increased risk of chronic disease. Many participants were sent by their
employers for the examination; some were referred by their personal physicians; while the
rest were self-referred.
2.2. Baseline examination
Each individual underwent a thorough medical evaluation that included personal and family
health history, a physical examination, a questionnaire on health habits, anthropometry
measurement, fasting blood chemistry analyses, resting blood pressure and
electrocardiogram, and a maximal exercise test [32]. Examination methods and procedures
followed a standard manual of operations, as described in detail previously [32]. Briefly,
body mass and stature were measure using a standard physician’s scale and stadiometer, and
the body mass index [BMI = weight(kg)/height(m)2] was calculated. Waist circumference
was measured level with the umbilicus. Resting blood pressure was recorded as the first and
fifth Korotkoff sounds by ausculatatory methods. Men who reported a history of physician-
diagnosed hypertension or who had blood pressures ≥ 140/90 mmHg at the examination
were classified as having hypertension. Serum samples were analyzed for lipids and glucose
using standardized automated bioassays by a laboratory that participates in and meets
quality control standards of the CDC Lipid Standardization Program. Hypercholesterolemia
was defined as a fasting total cholesterol level ≥ 240 mg/dL. Diabetes was defined as a
fasting plasma glucose level ≥ 126 mg/dL, self-reported physician diagnosed diabetes, or
taking insulin. Information on smoking habits (whether a current smoker), alcohol intake
(number of drinks per week), leisure-time physical activity, and family history of PrCA was
obtained from a standardized questionnaire.
Cardiorespiratory fitness was assessed at the baseline examination as the duration of a
symptom-limited maximal treadmill exercise test using a modified Balke protocol [33]. The
treadmill speed was 88m · min−1 for the first 25 min. During this time the grade was 0% for
the first minute, 2% the second minute, and increased 1% each minute until 25 min had
elapsed. After 25 min, the grade remained constant while the speed increased 5.4 m · min−1
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each minute until test termination. Patients were encouraged to give a maximal effort during
the test. All men in the present analyses were able to complete the test to at least 85% of
their age-predicted maximal heart rate (220 minus age in years). The duration of the
maximal exercise treadmill test on this protocol is highly correlated with directly measured
maximal oxygen uptake in men (r = 0.92), an accepted measure of CRF [34]. Maximal
metabolic equivalents (METs, 1 MET = 3.5 ml O2 uptake · kg−1 · min−1) were estimated
from the final treadmill speed and grade [35]. We used our previously published [36] age-
specific distributions of treadmill duration from the overall ACLS population to define
fitness groups as low (lowest 20%), moderate (middle 40%), and high (upper 40%) to
maintain consistency in the study methods. The respective cut points for total treadmill time
and METs in the low, moderate, and high-fitness groups were described in detail in a recent
report [36]. Exercise test durations (minutes) for the incremental fifths of fitness categories
for men were: < 7.8, 7.8–10.5, 10.5–13.1, 13.1–16.4, and >16.4. In equivalent METs values,
the thresholds that defined these categories were 7.2, 8.5, 9.5, and 10.8 METs.
2.3. Ascertainment of incident prostate cancer cases
PrCA incidence was ascertained from responses to mail-back health surveys in 1982, 1990,
1999, and 2004. Thus, men were followed for prostate cancer from 1976 through 2004. The
aggregate survey response rate across all survey periods in the ACLS is ≈ 65%.
Nonresponse bias, a concern in epidemiological surveillance, has been investigated in the
ACLS [37], and found to be unlikely to present a major source of bias. Baseline health
histories and clinical measures were similar between responders and nonresponders and
between early and late responders [37]. The endpoint was defined as a participant report of
physician-diagnosed PrCA and has been described in detail elsewhere [31].
2.4. Statistical analysis
Follow-up time among noncases was computed as the difference between the date of the
baseline examination and the date of the last returned survey where the participant reported
being free of PrCA. Follow-up time among cases was computed as the difference between
the baseline examination date and the reported date of the PrCA event. If a diagnosis date
was not provided on the survey, we used the midpoint between the date of the case-finding
survey and either the baseline examination date or the date of the last returned survey where
the participant reported being free of PrCA. The time-axis used in modeling was years.
Baseline characteristics of the population were compared according to CRF levels. General
linear models and χ2-tests were used to test mean and frequency differences in covariates,
respectively. Cox proportional hazards regression models were used to examine adjusted
hazard ratios (HRs), 95% confidence intervals (95% CIs), and incidence rates (cases per
10,000 person-years of follow-up), using men in the lowest CRF level as the reference
category. Multivariable-adjusted models included age (yr), examination year (single year),
physical activity (low, moderate, high), smoking status (never, former, current), alcohol
intake (drinks/week), family history of PrCA (yes, no), diabetes (yes, no), hypertension (yes,
no), hypercholesterolemia (yes, no), waist circumference (WC) (cm), and BMI (kg/m2) as
potential confounders. Multicollinearity among independent variables in the models was
tested and we found no significant collinearity based on variance inflation factors. Kaplan-
Meier survival curves also were constructed to compare the probability of developing
incident PrCA across CRF levels. To determine whether the association between CRF and
PrCA risk differed by follow-up examinations, PrCA diagnosis year, age, or body weight,
we conducted the stratified analyses by follow-up examinations (No vs. Yes), PrCA
diagnosis year (≤ 1995 vs. > 1995), age (<55 vs. ≥55 years), waist circumference (≤ 102 vs.
>102 cm), and BMI (18.5–29.9 vs. ≥ 30 kg/m2) categories. All statistical analyses were
performed using Statistical Analysis Systems software, version 9.1 (SAS Inc., Cary, NC).
All P values were 2-sided, and 95% CIs were considered to indicate statistical significance.
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The baseline characteristics of the participants according to baseline levels of CRF are
presented in Table 1. The mean age, CRF (in METs), and BMI of 19,042 men were 45.6 ±
9.7 years, 12.0 ± 2.4 METs, and 26.2 ± 3.5 kg/m2 respectively. Overall, men with higher
CRF level had more favorable baseline characteristics, including lower prevalence of
diabetes, hypertension, and hypercholesterolemia (ptrend < 0.0001). We also examined the
characteristics of men, according to the number of follow-up examinations that they had
after the baseline examination (Fig 1). Overall, the data indicated that men with more
follow-up examinations at the clinic were more likely to have optimal baseline
characteristics, including CRF (presented as METs), BMI, alcohol intake, smoking status,
and disease prevalence.
There were 634 PrCA cases identified during an average of 9.3 ± 7.1 years of follow-up.
After adjusting for age, examination year, significantly higher risks of PrCA were observed
in men with higher CRF levels (Table 2). After further adjusting for physical activity,
current smoking, alcohol intake, family history of PrCA, diabetes, hypertension,
hypercholesterolemia, and BMI, men with moderate and high CRF level had 68% higher
risk of being diagnosed with PrCA (HR, 1.68; 95% Confidence Interval, 1.13–2.48) and
74% higher PrCA risk (HR, 1.74; 95% CI, 1.15–2.62), respectively, compared to men with
low CRF (P trend < 0.05). In a subgroup of men for whom prostate-specific antigen (PSA)
test results were available (N=3,003), there was no significant association between CRF and
PrCA, without and with adjustment for PSA scores.
To determine whether there was effect modification by several risk factors for PrCA, we
examined the association between CRF and risk of PrCA, stratified by age, waist
circumference, BMI, and follow-up examination after adjustment for several potential
confounders (Table 3). We found borderline significant statistical evidence of qualitative
interaction between CRF and BMI (χ2df=1 = 3.81, P = 0.05), and follow-up examination
(χ2df=1 = 2.13, P = 0.14), but no statistical evidence in support of the association between
CRF and WC (χ2df=1 = 1.53, P = 0.21), and age (χ2df=1 = .01, P = 0.91). A statistically
significant positive association between CRF and PrCA risk was observed among men who
were normal weight or overweight, and among men with follow-up examination, but not
among those who were obese, or those without follow-up.
Because of the dramatic increase in the use of the PSA test after it was introduced to the
public in 1986 [38], we sought to determine whether a period effect existed. Therefore, we
examined the association between CRF and PrCA by diagnosis year (Table 3). We chose
1995 as our cut-point year because the incidence of PrCA increased dramatically after 1986
when PSA test was introduced to the public, peaked about 1992–1993, and then leveled off
about 1995 [38]. We found a significant direct association between CRF and PrCA, which
showed that men with moderate CRF level had an HR of 3.00 (95% CI, 1.38–6.55) and
those with high CRF level had and HR of 3.17 (95% CI, 1.41–7.10); i.e., three times higher
PrCA incidence than men with low CRF level among men who were diagnosed with PrCA
up to 1995. However, there was a suggestion of a negative association among men who were
diagnosed with PrCA after 1995. The Kaplan-Meier curves showing PrCA incidence rates
according to CRF level are shown in Figure 2.
4. Discussion
In the current study, we found an unexpected positive association between CRF, as
measured by a maximal treadmill exercise test, and risk of PrCA. These results, obtained
after adjusting for potential confounders such as smoking, alcohol intake, obesity, and other
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disease (i.e., co-morbid) status, were at odds with hypothesized mechanisms, some of the
published literature on physical activity and PrCA (in particular, several large cohort studies
have shown a benefit of physical activity on PrCA risk [18–20]) and previous findings from
this study, published in 1996 showing 74% and 63% lower risk of PrCA among men in the
highest quartile of CRF and physical activity, respectively [31]. As such, they point out the
need to exercise caution in the interpretation of study results, especially in areas of research
that are affected by changes in the public’s perception of the utility of tests used for cancer
screening.
Inconsistent findings from previous reports may be due to limited sample sizes (including
our own earlier study in this cohort [31]), imprecise assessments of physical activity,
variation in the control for confounding, or residual confounding by unknown factors which
need further investigation. There exist several possible explanations for our findings that
underline the importance of understanding the role of potential confounders and the
unconventional ways in which they might work in relation to incident PrCA:
First, men with moderate-to-high CRF may be more likely to participate in the study. Such
men also may be more likely to return more surveys over time. On the other hand, men with
low CRF may be less likely to participate and also have more co-morbidities that may
diminish their enthusiasm for PSA screening, hence resulting in a lower probability for a
PrCA diagnosis. Similarly, they may not have enough longevity to develop PrCA because
they are at significantly greater risk of mortality from other causes than are men with
moderate-to-high CRF [32]. In our data, men with moderate-to-high CRF had longer
average follow-up time than men with low CRF (7.9 years vs. 9.4 years). Therefore,
defining PrCA incidence via mail-back survey may be one of the sources of bias in the
current study.
Second, although we adjusted for numerous potential confounders in the analysis, there is
possibility of confounding by other unmeasured factors, such as endogenous hormones, diet
(especially fat intake), and genetic variants, which is always a concern in an observational
study. Though it is possible that one or more such factors is operative, it is unlikely that any
combination of exposure-related factors could explain such a large change in the direction
and magnitude of the observed effect in the period before 1995 vs. afterward.
Third, men with moderate-to-high CRF probably are more health-conscious in general.
Thus, they may have been more likely to avail themselves of widely accessible opportunities
to be diagnosed with PrCA and be more likely to obtain PSA screening. PrCA is primarily
an indolent cancer whose apparent incidence increased as an artifact of the wide availability
and increased use of PSA screening from the late 1980s through the mid-1990s [38]. The
observed higher prostate cancer incidence may be a result of increased health consciousness
and screening in men with high CRF than in men with low CRF. This is supported by our
observation that men with moderate-to-high CRF had better baseline health profiles and
lower prevalence of diseases. Also, men with moderate or high CRF were more likely to
revisit the clinic (49.3% vs. 34.3%), be screened for PSA (16.2% vs. 12.3%), and be
diagnosed with PrCA (3.5% vs. 1.5%) compared to men who were in the low CRF level.
Some previous epidemiologic studies have reported increased risk of PrCA among more
physically active men compared to their inactive counterparts [21,23–26]. In addition, these
studies examined whether the association between physical activity and PrCA differed
among subgroups according to age, overweight/obese, PSA screening, and PrCA stage (i.e.,
localized vs. advanced or tumor aggressiveness) [21,23–25]. This is consistent with results
from a hospital-based case-control study [39] and cohort studies reporting a positive
association between occupational physical activity [40], non-occupational physical activity
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and sports participation [25], sports play [26], and leisure-time and home maintenance
physical activity [21]. The overall range of increased relative risks or odds ratios in those
studies was from 1.63 to 2.16, and the reported associations in subgroups were not
consistent across these studies. However, due to heterogeneity of study design, physical
activity measurement, and categorization of physical activity as exposure, it is difficult to
compare our study with previous ones reporting a positive association.
It is interesting to note that two of the cohort studies [41,42] that showed a positive
association between physical activity and PrCA risk also showed inverse (protective)
associations between levels of physical activity and all-cause mortality, similar to what we
found in the ACLS cohort [32].
Consistent with the secular trend toward vastly increased use of the PSA test from the late
1980s through the mid-1990s [38], we also examined whether the association between CRF
and PrCA varied according to diagnosis year (≤ 1995 vs. >1995) to gauge the potential for
PSA-screening bias that the association between CRF and PrCA differs by period of
widespread adoption of the PSA test for screening. Our finding of a positive association
between CRF and PrCA among men who were diagnosed with PrCA up to 1995, versus a
suggestive of a negative association in men who were diagnosed with PrCA after 1995,
supports the hypothesis that the observed result in the earlier period is an artifact resulting
from an “early-adopter” effect. That is, the most health-conscious men were the ones both
most likely to be fit and to be early users of the PSA test (and therefore be more likely to
have a diagnosis of incident PrCA).
There is some support for this alternate explanation in that when analyses were restricted
only to men with PSA screening results, we observed no association between CRF and
PrCA risk. Another way to minimize the effect of screening bias would be to examine only
fatal prostate cancer. Unfortunately we did not have enough data to further explore this,
because only 19 men died from PrCA during this period.
On balance, we believe that the most likely explanation of the unexpected association
observed in this study can be ascribed to an early-adopter effect in more fit men. This, in
turn, is related to a dramatic increase of incident PrCA known to be associated with PSA
screening, which became popular in the United States from late 1980s and increased
reported incidence through the mid-1990s [38]. Even though the early detection in PrCA is
encouraged by some groups, it has been suggested that overdiagnosis from PrCA screening
is not uncommon [43,44]. It is interesting to note that more recent studies such as in the
European Prospective Investigation into Cancer and Nutrition (EPIC) cohort conducted in
Europe where PSA screening is less popular than in the US, are broadly consistent with
what we found in the ACLS in this latter period (i.e., after 1995) [45].
In summary the unexpected association we observed is most likely due to a screening/
detection bias in more fit men, rather than a causal association. It most likely reflects an
overdiagnosis of PrCA cases compared to what was available in our previous work [31],
which used data obtained primarily in the period prior to the upsurge in PSA screening.
This study has several strengths and limitations that should be considered. Strengths include
its prospective study design, relatively large sample, long follow-up period, and extensive
baseline examination including objective maximal treadmill test for CRF and identified
potential confounders. In addition, no previous study, except for the one conducted
previously in the same cohort, has examined the relationship between PrCA and CRF [32].
It has been suggested that the relationship of physical activity with PrCA risk may vary by
PSA screening and stage of PrCA [20,23]. Therefore, a major weakness is that we did not
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have complete data on PSA screening, which limited these analyses to 3,003 men. It is
unlikely, however, that such factors could explain much of the positive association observed
in the earlier (i.e., pre-1995) period. Due to the widespread geographic distribution of
participants evaluated at the Cooper Clinic we were unable to verify all reported PrCA
cases. However, the ACLS population is well-educated and based on the relatively high
agreement between participant’s self-reported history such as hypertension [46,47], heart
attack [36], stroke [48], or diabetes [49–51] and their medical records, we also suspect that
there was an acceptable level of accuracy for self-reported PrCA. Vigorous attempts to reach
all participants could not be implemented before the undertaking of the present analysis;
therefore, we did not have the ability to separate true nonresponders from those who never
received the mail survey and thus did not have the opportunity to respond. Finally,
generalizability of findings from this study is limited to well-educated European Americans
of middle-to-upper socioeconomic status.
In conclusion, there is inconsistency in the literature regarding the association between
physical activity and PrCA risk. We found a positive association between CRF and risk of
PrCA, which does not support the inverse association with moderate-to-high CRF that we
observed from our previous work in the same cohort. It is most likely that screening bias due
to more health-conscious behavior among men with moderate-to-high CRF, leading to
increased diagnosis of PrCA in these groups, played a role in these results. The results from
this study underline the importance of considering outcome ascertainment bias, especially
for a condition such as PrCA, which has been the center of so much debate, controversy, and
variations in use over time [43,52–54].
Future studies with complete PSA information, and detailed information on stage and
histopathological grade (i.e., Gleason score) of PrCA will be helpful to understand the
inconsistent association between CRF and PrCA risk that we observed. Because PrCA is
generally (>80%) not fatal [1] and concern is well placed regarding overdiagnosis of
indolent disease that will never kill a man [52,55], increased effort would be well advised to
identify and utilize very large cohorts capable of analyzing mortality as an outcome.
Likewise, increased focus on African-American men who are more likely to be diagnosed
with aggressive PrCA [56–58] and to die of the disease [1] would help to advance our
understanding. Future work also should focus on the combined role of diet and PA while
addressing potential biases in outcome ascertainment.
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Characteristics according to number of follow-up examination. Horizontal axis represents
number of follow-up examinations at the clinic after baseline examination. HTN,
Hypertension; HCL, Hypercholesterolemia; SMK, Smoking; DM, Diabetes Mellitus.
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Kaplan-Meier curves for prostate cancer incidence rate by cardiorespiratory fitness level in
men.
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TABLE 3
Hazard ratios prostate cancer associated with CRF, according to subgroups of men.
Cardiorespiratory fitness
P for interactionLow HR (95% CI)c Moderate HR (95% CI) High HR (95% CI)
Follow-up examinationa
 No 1.00 (Reference) 1.25 (0.75–2.07) 1.26 (0.74–2.15)
0.14
 Number of cases 19 90 137
 Yes 1.00 (Reference) 2.36 (1.23–4.53) 2.48 (1.27–4.85)
 Number of cases 10 126 252
PrCA diagnosis yearb
 ≤ 1995 1.00 (Reference) 3.00 (1.38–6.55) 3.17 (1.41–7.10)
<0.001
 Number of cases 7 89 141
 > 1995 1.00 (Reference) 0.72 (0.45–1.16) 0.85 (0.52–1.40)
 Number of cases 22 127 248
Age (yr)
 <55 1.00 (Reference) 1.26 (0.76–2.01) 1.43 (0.84–2.43)
0.91
 Number of cases 19 113 223
 ≥55 1.00 (Reference) 2.25 (1.18–4.32) 1.98 (1.05–3.83)
 Number of cases 10 103 166
Waist circumference (cm)
 ≤ 102 1.00 (Reference) 2.08 (1.18–3.65) 2.11 (1.20–3.73)
0.21
 Number of cases 13 172 362
 > 102 1.00 (Reference) 1.12 (0.62–1.97) 1.45 (0.71–2.76)
 Number of cases 16 44 27
Body mass index (kg/m2)
 18.5–29.9 1.00 (Reference) 1.91 (1.18–3.14) 2.00 (1.21–3.30)
0.05
 Number of cases 2 67 240
 ≥30.0 1.00 (Reference) 0.92 (0.45–1.89) 0.53 (0.171.62)
 Number of cases 27 149 149
a
Follow-up examination defined as men who had at least one follow-up examination (Yes) or men who had no follow-up examination (No) after
baseline examination.
b
PrCA diagnosis year defined as men who were diagnosed PrCA up to 1995 (≤1995) or after 1995 (> 1995).
c
Hazard ratio (HR) adjusted for age (single year), examination year, physical activity, current smoking, alcohol intake, family history of prostate
cancer, diabetes, hypertension, hypercholesterolemia, WC (for BMI), and BMI (for WC).
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